These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 24166587

  • 1. Successful treatment of POEMS syndrome with bortezomib and dexamethasone, combined with radiotherapy, and followed by autologous stem cell transplantation.
    Ishii Y, Yamazaki E, Ishiyama Y, Yamamoto E, Hattori Y, Hagihara M, Tomita N, Ishigatsubo Y.
    Int J Hematol; 2013 Dec; 98(6):723-8. PubMed ID: 24166587
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effective induction therapy with subcutaneous administration of bortezomib for newly diagnosed POEMS syndrome: a case report and a review of the literature.
    Zeng K, Yang JR, Li J, Wei Q, Yang YM, Liu T, Niu T.
    Acta Haematol; 2013 Dec; 129(2):101-5. PubMed ID: 23171959
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. POEMS Syndrome: Therapeutic Options.
    Jaccard A.
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):141-151. PubMed ID: 29157615
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial.
    Kim HJ, Yoon SS, Lee DS, Sohn SK, Eom HS, Lee JL, Chung JS, Kim K, Suh C, Won JH, Kim JS, Park JS, Kang HJ, Seong CM, Kim CS, Lee SJ, Lee JH.
    Ann Hematol; 2012 Feb; 91(2):249-56. PubMed ID: 21789621
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. POEMS Syndrome: Indian Experience From a Tertiary-Care Institute.
    Pramanik R, Sharma A, Sharma A, Gogia A, Sahoo RK, Malik PS, Padma MV, Cyriac SL, Kumar L.
    Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):e536-e544. PubMed ID: 31262669
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Bortezomib-based induction therapy followed by autologous hematopoietic stem cell transplantation in multiple myeloma].
    Huang B, Li J, Liu J, Gu J, Zheng D, Xu D, Zou W, Wang H.
    Zhonghua Nei Ke Za Zhi; 2014 Nov; 53(11):865-72. PubMed ID: 25586356
    [Abstract] [Full Text] [Related]

  • 16. [New treatment strategy for Crow-Fukase (POEMS) syndrome].
    Kuwabara S.
    Rinsho Shinkeigaku; 2010 Nov; 50(11):794-6. PubMed ID: 21921444
    [Abstract] [Full Text] [Related]

  • 17. [Treatment for POEMS syndrome with subcutaneous administration of bortezomib followed by autologous peripheral blood stem cell transplantation: a case report and literatures review].
    Zeng K, Liu ZG, Yang JR, Hou L, Yang YM, Liu T, Niu T.
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):550-2. PubMed ID: 23827121
    [No Abstract] [Full Text] [Related]

  • 18. Ixazomib Combined With Autologous Stem Cell Transplantation for POEMS Syndrome: A Case Report and Meta-Analysis.
    Ma J, Wang X, Lu H, Liang Z, Wang L.
    Technol Cancer Res Treat; 2022 Jun; 21():15330338221123634. PubMed ID: 36579839
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Bortezomib plus dexamethasone treatment followed by reduced-intensity allogeneic stem cell transplantation for multiple myeloma refractory to high-dose chemotherapy with autologous transplantation].
    Hayashi T, Yasui H, Kawakami K, Ikeda H, Takahashi F, Kobayashi T, Nishimura S, Ishida T, Imai K, Shinomura Y.
    Rinsho Ketsueki; 2011 Mar; 52(3):136-41. PubMed ID: 21471701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.